Our technology platform includes proprietary processes that improve the production of polymers which are tailorable to meet the needs of the indication.
We have one of the most experienced team of polymer formulators in the world and they are situated in our R&D centres in Finland and the UK, where we also have a dedicated medical grade biopolymer manufacturing facility.
Our polymer gel-based technology platform SISU® enables us to tailor and enhance the release profile and duration of long-acting injectable small molecule and biomolecule drugs from a week to months.